Results Of The Large Prospective Study On The Use Of Defibrotide (DF) In The Treatment Of Hepatic Veno-Occlusive Disease (VOD) In Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome - Updated Results Of a Treatment IND (T-IND) Expanded Access Protocol
Year: 2013
Type: article
Source: Blood
Authors: Paul G. Richardson, Angela R. Smith, Brandon M. Triplett, Nancy A. Kernan, Stephan A Grupp, Sally Arai, Paul R. Haut, Paul L. Martin, Heather J. Symons, Leslie E. Lehmann, Tiffany Simms-Waldrip, Alfred P. Gillio, Biljana N. Horn, Tsiporah B. Shore, Amrita Y. Krishnan, Aleksandra Petrovic, Ivan I. Kirov, Ann E. Woolfrey, Robert J. Greiner, Shin Mineishi, Michael Boyer, Alison L. Hannah, Joseph H. Antin, Robin Hume, Valeria Bandiera, Carin Heringa, Robert J. Soiffer, Defibrotide Study Group
Institutions: Dana-Farber Cancer Institute, University of Minnesota, St. Jude Children's Research Hospital, Memorial Sloan Kettering Cancer Center, Children's Hospital of Philadelphia, Stanford Health Care, Stanford University, Indiana University Indianapolis, Indiana University School of Medicine, Duke University, Johns Hopkins University, The University of Texas Southwestern Medical Center, Hackensack University Medical Center, University of California, San Francisco, UCSF Benioff Children's Hospital, NewYork–Presbyterian Hospital, City Of Hope National Medical Center, City of Hope, Johns Hopkins All Children's Hospital, Children's Hospital of Orange County, Fred Hutch Cancer Center, Pennsylvania State University, Penn State Health Children's Hospital, Penn State Milton S. Hershey Medical Center, University of Alabama at Birmingham, Primary Children's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W292630624